Reportlinker Adds Booming Generics Drug Market in India

NEW YORK, May 24 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Booming Generics Drug Market in India

Generic drugs have become a new area of interest for pharmaceutical manufacturers. After the recession, demand for generic drugs has significantly soared due to the low cost factor. India is considered as one of the fastest growing pharmaceutical markets in the world. The introduction of product patent regime has put the industry growth on a new path. As per our new research report "Booming Generics Drug Market in India", the generic drugs market in India is projected to grow at a CAGR of around 16.3% during FY 2011-FY 2013.

Our team of industry experts has found that generic drugs exports from India have seen a significant surge over the last few years. The European and African countries have been added as new destinations for exports. The US and East Asian countries will remain a vital importing destinations for Indian generic products. In future, the exports are expected to pick up pace as healthcare reform in the US and other countries will inflate demand for generic drugs.

Our experts also indicate that several new trends have crept into the industry along with developments. The report provides a complete analysis on these new trends to facilitate the client understand them and plan their investment strategies accordingly. The report also contains information about the regulatory environment that has done an outstanding job in the development of generic industry in India. Besides, it provides information of various industry roadblocks that need to be addressed for sustaining the growth trend. Thus, the report presents a true and unbiased picture of the industry and help the client in making investments decision.

The report is an outcome of comprehensive research and rational analysis of various segments like API and formulation drugs of Indian generic and pharmaceutical market. It provides statistical data and analysis of ongoing and future trends to facilitate a deep market understanding. The future projections are made after analyzing the current market scenario, past trends and ongoing developments in the market. A detailed overview of competitive landscape has also been included to provide a balanced research approach.

1. Analyst View

2. Research Methodology

3. Indian Generics Market - An Overview

4. Key Market Drivers

4.1 Increasing Export

4.2 Private Investments

4.3 Patent Expiries

4.4 Increasing Acceptance of Generics

5. Industry Performance

5.1 Market Size and Growth

5.2 Branded and Generics

6. Opportunities for Indian Generics Companies

6.1 US

6.2 Europe

6.3 Japan

6.4 African Countries

7. Emerging Industry Trends

8. Regulatory Environment

9. Industry Restraints and Recommendations

9.1 Counterfeit Drugs

9.2 Lack of Government Initiatives

9.3 Quality Issues

10. Competitive Landscape

10.1 Industry Structure

10.2 Key Deals & M&As

10.3 Key Players

10.3.1 Ranbaxy

10.3.2 Cipla Ltd.

10.3.3 Jubilant Organosys

10.3.4 Sun Pharmaceuticals

10.3.5 Zydus Cadila

10.3.6 Dr. Reddy's Laboratories

10.3.7 Lupin Ltd.

10.3.8 Aurobindo Pharma

10.3.9 Glenmark Pharma

10.3.10 Piramal Healthcare

List of Figures:

Figure 4-1: Drugs and Pharmaceutical Export (Billion INR), 2004-05 to 2008-09

Figure 5-1: Pharmaceutical Market (Billion INR), FY 2009 to FY 2013

Figure 5-2: Generics Drug Market (Billion INR), FY 2009 to FY 2013

Figure 5-3: Share of Generics in Pharmaceutical Market (FY 2010)

List of Tables:

Table 4-1: Blockbuster Drugs Going Off-patent Globally (2010 to 2012)

Table 10-1: Key M&As in Indian Pharma Industry

Table 10-2: Ranbaxy Laboratories Ltd. - Strengths and Weaknesses

Table 10-3: Cipla Ltd. - Strengths and Weaknesses

Table 10-4: Jubilant Organosys - Strengths and Weaknesses

Table 10-5: Sun Pharmaceuticals - Strengths and Weaknesses

Table 10-6: Zydus Cadila - Strengths and Weaknesses

Table 10-7: Dr. Reddy's Laboratories - Strengths and Weaknesses

Table 10-8: Lupin Ltd. - Strengths and Weaknesses

Table 10-9: Aurobindo Pharma - Strengths and Weaknesses

Table 10-10: Glenmark Pharma - Strengths and Weaknesses

Table 10-11: Piramal Healthcare - Strengths and Weaknesses

To order this report:

Generic Drug Industry: Booming Generics Drug Market in India

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg


Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker